Grade: Pharmaceutical Grade

Factory Location: Huashan West Road Medical Park, Huayin City, Shaanxi Province

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: yes

Payment Terms: L/C

Febuxostat is a selective xanthine oxidase inhibitor with the molecular formula C₁₆H₁₆N₂O₃S and CAS number 144060-53-7. It is primarily used to treat gout and hyperuricemia by inhibiting uric acid synthesis to reduce serum uric acid levels, making it suitable for long-term uric acid-lowering therapy. Its efficacy is superior to that of traditional drugs such as allopurinol, particularly offering greater safety for patients with impaired renal function. Common formulations include 40mg/80mg tablets, which must be used under medical supervision and may cause side effects such as liver function abnormalities. As a novel anti-gout medication, febuxostat is recommended as a first-line treatment option in guidelines from multiple countries.